Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulation During Pregnancy Through Low-Dose Aspirin: a Hypothetical Mechanism for the Prevention of Preeclampsia?

NCT06882850 is registered in ClinicalTrials.gov with Unidade Local de Saúde de Coimbra, EPE as lead sponsor.

NCT NCT06882850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06882850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulation During Pregnancy Through Low-Dose Aspirin: a Hypothetical Mechanism for the Prevention of Preeclampsia?
Lead sponsor
Unidade Local de Saúde de Coimbra, EPE
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2024
Completion date
March 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, immunology, pregnancy complications